All articles by  

  1. Chi-Med to end surufatinib’s Phase III SANET-ep trial early

    Hutchison China MediTech (Chi-Med) has reported positive data from interim analysis of the pivotal Phase III SANET-ep clinical trial of…
    Read More…

    17 Jun
  2. Noveome doses first subject in corneal epithelial defects trial

    Noveome Biotherapeutics has started dosing patients in a Phase II clinical trial of topical ocular delivery of ST266 to treat…
    Read More…

    17 Jun
  3. Concert Pharmaceuticals to launch Phase II schizophrenia trial

    Concert Pharmaceuticals has revealed plans to initiate a Phase II clinical trial of CTP-692 as an adjunctive treatment for schizophrenia,…
    Read More…

    14 Jun
  4. Novartis’ Cosentyx shows efficacy in psoriatic arthritis trial

    Novartis has announced that the Phase IIIb MAXIMISE clinical trial of its Cosentyx (secukinumab) drug met primary and key secondary…
    Read More…

    14 Jun
  5. Lumosa to assess stroke drug in Phase II clinical trial

    Taiwan-based Lumosa Therapeutics is set to launch a Phase II proof of concept clinical trial to evaluate its drug candidate…
    Read More…

    14 Jun
  6. Pfizer reports favourable outcomes for rheumatoid arthritis drug

    Pfizer has reported positive findings from the 12-month Phase IIIb/IV ORAL Shift clinical trial of Xeljanz (tofacitinib), a JAK inhibitor,…
    Read More…

    13 Jun
  7. CymaBay reports mixed results from NASH trial of seladelpar

    CymaBay Therapeutics has reported top-line, 12-week results from an ongoing Phase IIb clinical trial of seladelpar to treat nonalcoholic steatohepatitis…
    Read More…

    13 Jun
  8. PLAT-05 trial launches at Children’s National Health System

    Children’s National Health System in the US has initiated the PLAT-05 clinical trial of a chimeric antigen receptor (CAR) T-cell…
    Read More…

    13 Jun
  9. Homology Medicines begins Phase I/II study of PKU gene therapy

    Genetic drugs developer Homology Medicines has started patient enrolment in a Phase I/II clinical trial of its investigational gene therapy…
    Read More…

    12 Jun
  10. Trial shows cardiovascular safety with Novo Nordisk’s diabetes drug

    Novo Nordisk has reported that its oral semaglutide medicine showed non-inferiority compared to placebo in major adverse cardiovascular events (MACE)…
    Read More…

    12 Jun
Close
Close
Close

Go Top